Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegeneration

DA Butterfield, SS Hardas… - Journal of Alzheimer's …, 2010 - content.iospress.com
Abstract Recently, the oxidoreductase, glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), has become a subject of interest as more and more studies reveal a surfeit of …

[HTML][HTML] Plant cytoplasmic GAPDH: redox post-translational modifications and moonlighting properties

M Zaffagnini, S Fermani, A Costa, SD Lemaire… - Frontiers in plant …, 2013 - frontiersin.org
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a ubiquitous enzyme involved in
glycolysis and shown, particularly in animal cells, to play additional roles in several …

[HTML][HTML] Deciphering functional roles of protein succinylation and glutarylation using genetic code expansion

M Weyh, ML Jokisch, TA Nguyen, M Fottner, K Lang - Nature Chemistry, 2024 - nature.com
Post-translational modifications (PTMs) dynamically regulate cellular processes. Lysine
undergoes a range of acylations, including malonylation, succinylation (SucK) and …

[HTML][HTML] Target-selective protein S-nitrosylation by sequence motif recognition

J Jia, A Arif, F Terenzi, B Willard, EF Plow, SL Hazen… - Cell, 2014 - cell.com
S-nitrosylation is a ubiquitous protein modification emerging as a principal mechanism of
nitric oxide (NO)-mediated signal transduction and cell function. S-nitrosylases can use NO …

[HTML][HTML] CARM1 methylates GAPDH to regulate glucose metabolism and is suppressed in liver cancer

XY Zhong, XM Yuan, YY Xu, M Yin, WW Yan, SW Zou… - Cell reports, 2018 - cell.com
Increased aerobic glycolysis is a hallmark of cancer metabolism. How cancer cells
coordinate glucose metabolism with extracellular glucose levels remains largely unknown …

The triangle of death in Alzheimer's disease brain: the aberrant cross-talk among energy metabolism, mammalian target of rapamycin signaling, and protein …

F Di Domenico, E Barone, M Perluigi… - Antioxidants & redox …, 2017 - liebertpub.com
Significance: Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder and
represents one of the most disabling conditions. AD shares many features in common with …

Glycolytic enzyme inhibitors in cancer treatment

R Scatena, P Bottoni, A Pontoglio… - Expert opinion on …, 2008 - Taylor & Francis
Background: The radio-and chemotherapeutics currently used for the treatment of cancer
are widely known to be characterized by a low therapeutic index. An interesting approach to …

Dengue virus NS1 protein modulates cellular energy metabolism by increasing glyceraldehyde-3-phosphate dehydrogenase activity

D Allonso, IS Andrade, JN Conde, DR Coelho… - Journal of …, 2015 - Am Soc Microbiol
Dengue is one of the main public health concerns worldwide. Recent estimates indicate that
over 390 million people are infected annually with the dengue virus (DENV), resulting in …

High-resolution structure of human D-glyceraldehyde-3-phosphate dehydrogenase

JL Jenkins, JJ Tanner - Acta Crystallographica Section D …, 2006 - journals.iucr.org
GAPDH (d-glyceraldehyde-3-phosphate dehydrogenase) is a multifunctional protein that is
a target for the design of antitrypanosomatid and anti-apoptosis drugs. Here, the first high …

[HTML][HTML] Discovery of a spirocyclic 3-bromo-4, 5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity against pancreatic cancer cells

A Galbiati, S Bova, R Pacchiana, C Borsari… - European Journal of …, 2023 - Elsevier
Abstract Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a key glycolytic enzyme,
plays a crucial role in the energy metabolism of cancer cells and has been proposed as a …